RealManage's Mark Deen Named Corporate Recruiter
Jan 26, 2016 08:09 am UTC| Business
CARROLLTON, Texas, Jan. 26, 2016 -- RealManage is pleased to announce the hiring of Mark Deen to head up its corporate recruiting department. Mr. Deen is an accomplished business leader with 21 years of search industry...
City of Cape Town Uses ADVA FSP 3000 CloudConnect(TM) for 400G Metro Network Trial
Jan 26, 2016 08:08 am UTC| Business
CAPE TOWN, South Africa, Jan. 26, 2016 -- ADVA Optical Networking and the City of Cape Town announced today that they have successfully transmitted data rates of up to 400Gbit/s across Cape Town's metro transport network....
Pluristem to Present at Bio CEO & Investor Conference in New York City on February 8, 2016
Jan 26, 2016 08:00 am UTC| Business
HAIFA, Israel, Jan. 26, 2016 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, today announced that Dr. Karine Kleinhaus, the Company’s Divisional VP,...
Nidec Announces the Status of Share Repurchases and the Conclusion of the Share Repurchase Plan
Jan 26, 2016 07:30 am UTC| Business
KYOTO, Japan, Jan. 26, 2016 -- Nidec Corporation (NYSE:NJ) (the ”Company”) today announces the status of the Company’s share repurchases under its repurchase plan in accordance with the Articles of Incorporation...
Jan 26, 2016 06:36 am UTC| Business
BAGNEUX, France, Jan. 26, 2016 -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage specialty biopharmaceutical company, today announced the appointment of Edward Jordan...
Jan 26, 2016 06:36 am UTC| Business
MARTINSRIED / MUNICH, Germany, Jan. 26, 2016 -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) today announced that the company earned a milestone payment with Bayer's initiation of a global phase 2...
Galapagos reports results with GLPG1205 in ulcerative colitis
Jan 26, 2016 06:35 am UTC| Business
Phase 2a study confirms good pharmacokinetics, safety and tolerability In ulcerative colitis patients, primary endpoint for efficacy was not met MECHELEN, Belgium, Jan. 26, 2016 -- GalapagosNV (Euronext ...